Biological Significance of Aminopeptidase N/CD13 in Thyroid Carcinomas

Cancer Research

Volumn 63, Issue 23, 2003, Pages 8500-8506

  Kehlen, Astrid ^a   Lendeckel, Uwe ^b   Dralle, Henning ^a   Langner, Jürgen ^a   Hoang Vu, Cuong ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; DIPEPTIDYL PEPTIDASE IV; EPIDERMAL GROWTH FACTOR; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MICROSOMAL AMINOPEPTIDASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR CELL; TUMOR GROWTH; UNDIFFERENTIATED CARCINOMA;

ADULT; AGED; ANTIGENS, CD13; ANTIGENS, CD26; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; THYROID NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0347626098     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Gimm, O. Thyroid cancer, Cancer Lett., 163: 143-156, 2001.
2. Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., and Shafie, S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (Lond.), 284: 67-68, 1980.
3. Iwata, S., and Morimoto, C. CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation. J. Exp. Med., 190: 301-306, 1999.
4. Shipp, M. A., and Look, A. T. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key! Blood, 82: 1052-1070, 1993.
5. Riemann, D., Kehlen, A., and Langner, J. CD13: not just a marker in leukemia typing. Immunol. Today, 20: 83-88, 1999.
6. Bhagwat, S. V., Lahdenranta, J., Giordano, R., Arap, W., Pasqualini, R., and Shapiro, L. H. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Blood, 97: 652-659, 2001.
7. Thiele, K., Riemann, D., Navarrete, S. A., Langner, J., and Kehlen, A. Cell-cell contact of human T cells with fibroblasts changes lymphocytic mRNA expression: increased mRNA expression of interleukin-17 and interleukin-17 receptor. Eur. Cytokine Netw., 11: 53-58, 2000.
8. Weber, M., Uguccioni, M., Ochensberger, B., Baggiolini, M., Clark-Lewis, I., and Dahinden, C. A. Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. J. Immunol., 154: 4166-4172, 1995.
9. Saiki, I., Fujii, H., Yoneda, J., Abe, F., Nakajima, M., Tsuruo, T., and Azuma, I. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int. J. Cancer, 54: 137-143, 1993.
10. Hashida, H., Takabayashi, A., Kanai, M., Adachi, M., Kondo, K., Kohno, N., Yamaoka, Y., and Miyake, M. Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer. Gastroenterology, 122: 376-386, 2002.
11. Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R. A., Shapiro, L. H., Arap, W., and Ruoslahti, E. Aminopeptidase N in a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res., 60: 722-727, 2000.
12. Curnis, F., Arrigoni, G., Sacchi, A., Fischetti, L., Arap, W., Pasqualini, R., and Corti, A. Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Cancer Res., 62: 867-874, 2002.
13. Curnis, F., Sacchi, A., Borgna, L., Magni, F., Gasparri, A., and Corti, A. Enhancement of tumor necrosis factor α antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13). Nat. Biotechnol., 18: 1185-1190, 2000.
14. De Meesters, I., Korom, S., Van Damme, J., and Scharpe, S. CD26, let it cut or cut it down. Immunol. Today, 20: 367-375, 1999.
15. Morimoto, C., and Schlossman, S. F. The structure and function of CD26 in the T-cell immune response. Immunol. Rev., 161: 55-70, 1998.
16. Nemoto, E., Sugawara, S., Takada, H., Shoji, S., and Horiuch, H. Increase of CD26/dipeptidyl peptidase IV expression on human gingival fibroblasts upon stimulation with cytokines and bacterial components. Infect. Immun., 67: 6225-6233, 1999.
17. Gaetaniello, L., Fiore, M., de Filippo, S., Pozzi, N., Tamasi, S., and Pignata, C. Occupancy of dipeptidyl peptidase IV activates an associated tyrosine kinase and triggers an apoptotic signal in human hepatocarcinoma cells. Hepatology, 27: 934-942, 1998.
18. Hanski, C., Huhle, T., and Reutter, W. Involvement of plasma membrane dipeptidyl peptidase IV in fibronectin-mediated adhesion of cells on collagen. Biol. Chem. Hoppe-Seyler, 366: 1169-1176, 1985.
19. Loster, K., Zeilinger, K., Schuppan, D., and Reutter, W. The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site. Biochem. Biophys. Res. Commun., 217: 341-348, 1995.
20. Cheng, H. C., Abedl-Ghany, M., Elble, R. C., and Pauli, B. U. Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin. J. Biol. Chem., 273: 24207-24215, 1998.
21. Wesley, U. V., Albino, A. P., Tiwari, S., and Houghton, A. N. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J. Exp. Med., 190: 311-322, 1999.
22. Pethiyagoda, C. L., Welch, D. R., and Fleming, T. P. Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells. Clin. Exp. Metastasis, 18: 391-400, 2000.
23. Kajiyama, H., Kikkawa, F., Suzuki, T., Shibata, K., Ino, K., and Mizutani, S. Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma. Cancer Res., 62: 2753-2757, 2002.
24. Aratake, Y., Kotani, T., Tamura, K., Araki, Y., Kuribayashi, T., Konoe, K., and Ohtaki, S. Dipeptidyl aminopeptidase IV staining of cytologic preparations to distinguish benign from malignant thyroid diseases. Am. J. Clin. Pathol., 96: 306-310, 1991.
25. Kotani, T., Aratake, Y., Ogata, Y., Umeki, K., Araki, Y., Hirai, K., Kuma, K., and Ohtaki, S. Expression of dipeptidyl aminopeptidase IV activity in thyroid carcinoma. Cancer Lett., 57: 203-208, 1991.
26. Kotani, T., Kawano, J., Suganuma, T., Hirai, K., Umeki, K., Aratake, Y., Konoe, K., and Ohtaki, S. Immunohistochemical localization of dipeptidyl aminopeptidase IV in thyroid papillary carcinoma. Int. J. Exp. Pathol., 73: 215-222, 1992.
27. Iwabuchi, H., Toriya, K., Mimura, T., Tamai, S., Ito, K., and Kato, H. Staining for dipeptidyl aminopeptidase IV activity in nodular thyroid diseases. Acta Cytol., 40: 158-163, 1996.
28. Sobin, L. H., and Fleming, I. D. TNM Classification of Malignant Tumors, 5th ed. (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer (Phila.), 80: 1803-1804, 1997.
29. Hoelting, T., Zielke, A., Siperstein, A. E., Clark, O. H., and Duh, Q. Y. Aberrations of growth factor control in metastatic follicular thyroid cancer in vitro. Clin. Exp. Metastasis, 12: 315-323, 1994.
30. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
31. Kehlen, A., Thiele, K., Riemann, D., and Langner, J. Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis. Clin. Exp. Immunol., 127: 539-546, 2002.
32. Bustin, S. A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol., 25: 169-193, 2000.
33. Aratake, Y., Umeki, K., Kiyoyama, K., Hinoura, Y., Sato, S., Ohno, A., Kuribayashi, T., Hirai, K., Nabeshima, K., and Kotani, T. Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules. Diagn. Cytopathol., 26: 366-372, 2002.
34. Kehlen, A., Gohring, B., Langner, J., and Riemann, D. Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators. Clin. Exp. Immunol., 111: 435-441, 1998.
35. Kido, A., Krueger, S., Haeckel, C., and Roessner, A. Possible contribution of aminopeptidase N (APN/CD13) to invasive potential enhanced by interleukin-6 and soluble interleukin-6 receptor in human osteosarcoma cell lines. Clin. Exp. Metastasis, 17: 857-863, 1999.
36. Basolo, F., Fiore, L., Pollina, L., Fontanini, G., Conaldi, P. G., and Toniolo, A. Reduced expression of interleukin 6 in undifferentiated thyroid carcinoma: in vitro and in vivo studies. Clin. Cancer Res., 4: 381-387, 1998.
37. Hoelting, T., Goretzki, P. E., and Duh, Q. Y. Follicular thyroid cancer cells: a model of metastatic tumor in vitro. Oncol. Rep., 8: 3-8, 2001.
38. Hoelting, T., Siperstein, A. E., Clark, O. H., and Duh, Q. Y. Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo. J. Clin. Endocrinol. Metab., 79: 401-408, 1994.
39. Duh, Q. Y., and Clark, O. H. Factors influencing the growth of normal and neoplastic thyroid tissue. Surg. Clin. N. Am., 67: 281-298, 1987.
40. Westermark, K., Westermark B., Karlsson, F. A., and Ericson, L. E. Location of epidermal growth factor receptors on porcine thyroid follicle cells and receptor regulation by thyrotropin. Endocrinology, 118: 1040-1046, 1986.
41. Tangada, S. D., Peterson, R. D., and Funkhouser, J. D. Regulation of expression of aminopeptidase N in fetal rat lung by dexamethasone and epidermal growth factor. Biochim. Biophys. Acta, 1268: 191-199, 1995.
42. Thompson, S. D., Franklyn, J. A., Watkinson, J. C., Verhaeg, J. M., Sheppard, M. C., and Eggo, M. C. Fibroblast growth factors 1 and 2 and fibroblast growth factor receptor 1 are elevated in thyroid hyperplasia. J. Clin. Endocrinol. Metab., 83: 1336-1341, 1998.
43. Eggo, M. C., Hopkins, J. M., Franklyn, J. A., Johnson, G. D., Sanders, D. S., and Sheppard, M. C. Expression of fibroblast growth factors in thyroid cancer. J. Clin. Endocrinol. Metab., 80: 1006-1011, 1995.
44. Shingu, K., Sugenoya, A., Itoh, N., and Kato, R. Expression of basic fibroblast growth factor in thyroid disorders. World J. Surg., 18: 500-505, 1994.
45. Scornik, O. A., and Botbol, V. Bestatin as an experimental tool in mammals. Curr. Drug Metab., 2: 67-85, 2001.
46. Mathe, G. Bestatin, an aminopeptidase inhibitor with a multi-pharmacological function. Biomed. Pharmacother., 45: 49-54, 1991.
47. Yoneda, J., Saiki, I., Fujii, H., Abe, F., Kojima, Y., and Azuma, I. Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin). Clin. Exp. Metastasis, 10: 49-59, 1992.
48. Furuse, K., Fukuoka, M., Genka, K., Kato, H., Tsubura, E., Ohta, M., Nakai, H., Kinuwaki, E., Nakano, M., Ishikawa, S., et al. Double blind controlled study of ubenimex (Bestatin) against squamous cell lung cancer - a multicenter cooperative study. Gan To Kagaku Ryoho, 20: 1187-1194, 1993.
49. Ezawa, K., Minato, K., and Dobashi, K. Induction of apoptosis by ubenimex (Bestatin) in human non-small-cell lung cancer cell lines. Biomed. Pharmacother., 50: 283-289, 1996.
50. Helene, A., Beaumont, A., and Roques, B. P. Functional residues at the active site of aminopeptidase N. Eur. J. Biochem., 196: 385-393, 1991.
51. O'Connell, P. J., Gerkis, V., and d'Apice, A. J. Variable O-glycosylation of CD13 (aminopeptidase N). J. Biol. Chem., 266: 4593-4597, 1991.
52. Fujii, H., Nakajima, M., Saiki, I., Yoneda, J., Azuma, I., and Tsuruo, T. Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13. Clin. Exp. Metastasis, 13: 337-344, 1995.
53. Menrad, A., Speicher, D., Wacker, J., and Herlyn, M. Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res., 53: 1450-1455, 1993.
54. Ishii, K., Usui, S., Sugimura, Y., Yoshida, S., Hioki, T., Tatematsu, M., Yamamoto, H., and Hirano, K. Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion. Int. J. Cancer, 92: 49-54, 2001.
55. van Belzen, N., Dinjens, W. N., Diesveld, M. P., Groen, N. A., van der Made, A. C., Nozawa, Y., Vlietstra, R., Trapman, J., and Bosman, F. T. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab. Investig., 77: 85-92, 1997.
56. Piquemal, D., Joulia, D., Balaguer, P., Basset, A., Marti, J., and Commes, T. Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. Biochim. Biophys. Acta, 1450: 364-373, 1999.
57. Shimono, A., Okuda, T., and Kondoh, H. N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech. Dev., 83: 39-52, 1999.
58. Guan, R. J., Ford, H. L., Fu, Y., Li, Y., Shaw, L. M., and Pardee, A. B. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res., 60: 749-755, 2000.
59. van Belzen, N., Dinjens, W. N., Eussen, B. H., and Bosman, F. T. Expression of differentiation-related genes in colorectal cancer: possible implications for prognosis. Histol. Histopathol., 13: 1233-1242, 1998.
60. Kurdistani, S. K., Arizti, P., Reimer, C. L., Sugrue, M. M., Aaronson, S. A., and Lee, S. W. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res., 58: 4439-4444, 1998.
61. Lachat, P., Shaw, P., Gebhard, S., van Belzen, N., Chaubert, P., and Bosman, F. T. Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem. Cell Biol., 118: 399-408, 2002.
62. Hotta, H., Hara, I., Miyamoto, H., and Homma, M. Overexpression of the human melanoma-associated antigen ME491 partially suppresses in vivo malignant phenotypes of H-ras-transformed NIH3T3 cells in athymic nude mice. Melanoma Res., 1: 125-132, 1991.
63. Kondoh, M., Ueda, M., Ichihashi, M., and Mishima, Y. Decreased expression of human melanoma-associated antigen ME491 along the progression of melanoma pre-canceroses to invasive and metastatic melanomas. Melanoma Res., 3: 241-245, 1993.
64. Radford, K. J., Mallesch, J., and Hersey, P. Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). Int. J. Cancer, 62: 631-635, 1995.
65. Sordat, I., Decraene, C., Silvestre, T., Petermann, O., Auffray, C., Pietu, G., and Sordat, B. Complementary DNA arrays identify CD63 tetraspanin and α3 integrin chain as differentially expressed in low and high metastatic human colon carcinoma cells. Lab. Investig., 82: 1715-1724, 2002.
66. Boucheix, C., and Rubinstein, E. Tetraspanins. Cell. Mol. Life Sci., 58: 1189-1205, 2001.
67. Sauer, G., Kurzeder, C., Grundmann, R., Kreienberg, R., Zeillinger, R., and Deissler, H. Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells. Oncol. Rep., 10: 405-410, 2003.
68. Berditchevski, F., and Odintsova, E. Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling. J. Cell Biol., 146: 477-492, 1999.
69. Nilsson, M., Ekholm, R., Fayet, G., Maroux, S., and Ericson, L. E. Immunocytochemical localization of aminopeptidase N on the cell surface of isolated porcine thyroid follicles. Cell Tissue Res., 250: 295-303, 1987.
70. Santos, A. N., Langner, J., Herrmann, M., and Riemann, D. Aminopeptidase N/CD13 is directly linked to signal transduction pathways in monocytes. Cell Immunol., 201: 22-32, 2000.
71. Unoki, M., and Nakamura, Y. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene, 20: 4457-4465, 2001.